Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001731122-25-000252
Filing Date
2025-02-19
Accepted
2025-02-19 08:55:44
Documents
91
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A e6368_10-ka.htm   iXBRL 10-K/A 2074106
2 EXHIBIT 23.1 e6368_ex23-1.htm EX-23.1 3284
3 EXHIBIT 31.1 e6368_ex31-1.htm EX-31.1 14249
4 EXHIBIT 31.2 e6368_ex31-2.htm EX-31.2 13952
5 EXHIBIT 32.1 e6368_ex32-1.htm EX-32.1 6045
6 EXHIBIT 32.2 e6368_ex32-2.htm EX-32.2 5646
7 GRAPHIC image_002.jpg GRAPHIC 41867
8 GRAPHIC image_003.jpg GRAPHIC 41497
  Complete submission text file 0001731122-25-000252.txt   10316842

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE renb-20240630.xsd EX-101.SCH 80046
10 XBRL CALCULATION FILE renb-20240630_cal.xml EX-101.CAL 67476
11 XBRL DEFINITION FILE renb-20240630_def.xml EX-101.DEF 326291
12 XBRL LABEL FILE renb-20240630_lab.xml EX-101.LAB 565167
13 XBRL PRESENTATION FILE renb-20240630_pre.xml EX-101.PRE 492346
93 EXTRACTED XBRL INSTANCE DOCUMENT e6368_10-ka_htm.xml XML 1500168
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-38758 | Film No.: 25637587
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)